Our results suggested that FOSL1, CEBPD, MXI1 and YY1 were critical TFs of tumor invasion induced by hypoxia, and they can be used as an independent prognostic signature to predict GBM survival. The gene discussed is FOSL1; the disease is glioblastoma.